Call for Abstract

2nd International Conference on Neurological Disorders and Stroke, will be organized around the theme “Novel approaches and Developments in Neurological disorders and Stroke”

Stroke 2016 is comprised of 9 tracks and 115 sessions designed to offer comprehensive sessions that address current issues in Stroke 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Central nervous system disorder is a broad category of conditions in which the brain does not properly function, limiting health and organs functionality. The CNS disorders conditions include the result of damage from brain cancer, degenerative condition, infection, stroke, or problems rose from neurological factors. 

Meningitis is the neuroinfection or inflammation of the meninges, surrounded by three-layered membranes of the brain, spinal cord and the fluid and immersed in is called as cerebrospinal fluid. Whereas, Encephalitis which is defined as inflammation of the layers of tissue or membranes covering the brain. While the complexity of the central nervous system presents unique challenges for developing novel therapies.

  • Track 1-1Pathophysiology of CNS disorders
  • Track 1-2Spinal cord disorders
  • Track 1-3Neuronal and axonal damages
  • Track 1-4White matter diseases
  • Track 1-5Cranial nerve diseases
  • Track 1-6Cerebellum : Aging and cognitive syndrome
  • Track 1-7Coma: A state of unconsciousness
  • Track 1-8Brain dysfunction and its type
  • Track 1-9Brain: Infections and abscess
  • Track 1-10Therapeutic advancements in CNS disorders

Cerebrovascular disease is a severe, common and expensive disorder. It is third most frequent cause of death and leading cause of adult disability.  Of the 750,000 people suffer stroke annually 170,000 will die due to stroke.

The most common forms of cerebrovascular disease are cerebral thrombosis (40% of cases) and cerebral embolism (30%), followed by cerebral haemorrhage. Ischemia or hemorrhage are the by-products of cerebrovascular disease, manifest as sudden, focal neurological deficits related to specific vascular territories of the central nervous system.

Most patients with cerebrovascular disease have significant atherosclerosis, predisposed by one or more risk factors such as hypertensionheart diseasediabetes mellitus, smoking, hyperlipidemia, and family history of vascular disease. 

  • Track 2-1Epidemiology of cerebrovascular diseases
  • Track 2-2Hypertension
  • Track 2-3Cerebral embolism
  • Track 2-4Cerebral aneurysm
  • Track 2-5Transient ischaemic attack
  • Track 2-6Risk factors for cerebrovascular diseases
  • Track 2-7Technological advances in vascular surgery

Neurodegenerative disorder  is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. In some cases, the neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration or death of nerve cells. These include Alzheimer’s disease (AD) and other dementias, Parkinson’s disease (PD) and PD-related disorders, Prion disease, Motor neuron diseases (MND), Huntington’s disease (HD), Spinocerebellar ataxia (SCA), Spinal muscular atrophy and others. Each neurodegenerative disease is characterized through its unique aggregated protein. ß-amyloid (Aß) represents as hallmark of Alzheimer’s disease, whereas α-synuclein is the key protein in Parkinson’s disease and Dementia with Lewy bodies (DLB).

Today critical goal of medical research is the prevention and treatment of these neurodegenerative disorders. About 25 million people suffering from dementia and it is generally believed that it will rise to 130 million demented persons by 2050. The lack of effective treatments that can halt or reverse the disease process indicates a huge medical need.

  • Track 3-1Alzehimer
  • Track 3-2Parkinson
  • Track 3-3Multiple sclerosis disease
  • Track 3-4Amyotrophic Lateral Sclerosis Disease
  • Track 3-5Huntington
  • Track 3-6Prion disease
  • Track 3-7Neurodegeneration treatment advancements
  • Track 3-8Vascular coginitive impairment disorder

Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli. It may have continuous or episodic components. The latter resemble stabbings or electric shocks. Common qualities include burning or coldness, "pins and needles" sensations, numbness and itching. Over 30% of all neuropathic pain is a result of diabetes in the U.S.

Neuropathic pain classification is a taxonomic attempt by researchers and clinicians to sort out the myriad of disorders in order to conveniently study certain ‘syndromes’ with the idea of finding a treatment. Most neuropathic conditions are not isolated to pure pain fibres and can co-exist with inflammatory, visceral or nociceptive as well as neuropathic dysfunction like autonomic nervous system involvement in diabetes. Neuropathic pain includes toxic, metabolic, trauma, metabolic, cognitive, autoimmune and infectious disease.

  • Track 4-1Toxic, metabolic and trauma pain
  • Track 4-2Neuropathic pain in womens
  • Track 4-3Neuropathic pain and its therapeutics
  • Track 4-4Neuropathic infections
  • Track 4-5Diagnosis of neuropathic pain
  • Track 4-6Neuropathy and therapies
  • Track 4-7Advanced neuropathic therapies

brain tumour is a growth of cells in the brain that multiplies in an abnormally. Tumours of the brain produceneurological manifestations through a number of mechanisms. Small and critically located tumours may damage specific neural pathways traversing the brain. Tumours can invade, infiltrate, or supplant normal parenchymal tissue, disrupting normal functions. Metastatic brain tumours from non-CNS primary tumours may be the first sign of malignancy. Chemotherapy treatment of brain tumour is done with anti-cancer drugs, given to destroy or control cancer cells. Whereas, with application of measured doses of radiations cancer is treated. Although the risk associated with these therapies are high as it affects the normal cells also.

Neuro imaging includes employs new techniques to either directly or indirectly images the structure, function and pharmacology of the nervous system. Imaging of brain is a relatively new discipline within medicine and neuroscience or psychology. These imaging techniques include Magnetic Resonance ImagingPositron Emission Tomography and Single Photon Emission Computed TomographyMagnetic Resonance Spectroscopy, functional MRI, Electroencephalography and Magneto encephalograph with abilities that opened the door to direct observation of cognitive activities.

  • Track 5-1Pathophysiology of Brain tumour
  • Track 5-2Brain tumour Surgery
  • Track 5-3Radiation and Chemotherapy
  • Track 5-4Neurobiology of tumours
  • Track 5-5Invasive imaging of tumour
  • Track 5-6Non-invasive imaging of tumour
  • Track 5-7Structural and functional neuroimaging

Stroke is the third leading cause of death in Europe, USA, Canada and Japan and is the primary cause of adult disability and in this 80% are ischemic such as cardiogenic, atherosclerotic, haemodynamic, lacunar and cryptogenic. The acute ischemic stroke occurs when a blood clot blocks an artery that carries blood to the brain. The brain cell death rate is two million cells per minute in absence of oxygen, therefore increasing the risk of permanent brain injury, disability or death.

The Hemorrhagic stroke occurs when an artery in the brain bleeds. Aneurysm condition causes stroke that bursts or by a condition called arterial venous malformation, a twist of abnormal blood vessels in the brain that may bleed due to the fragility of the vessel structure. The goal of neurosurgery is to restore blood flow to the brain and reduce the risk of stroke. The type of graft and underlying conditions used is responsible for the effectiveness of bypass. 

  • Track 6-1Stroke Diagnosis
  • Track 6-2Coiling aneurysms
  • Track 6-3Endovascular and surgical treatments
  • Track 6-4Repair of vessels and blood clot removal
  • Track 6-5Bypass surgery¬†of brain
  • Track 6-6Carotid endarterectomy¬†
  • Track 6-7Neurointervention
  • Track 6-8Plaque depositions
  • Track 6-9Stroke prevention practices
  • Track 6-10Stroke Clinical guidelines
  • Track 6-11Stroke Anticoagulation and Prophylaxis
  • Track 6-12Rapid assessment and Imaging of stroke
  • Track 6-13Hemorrhagic stroke
  • Track 6-14Acute ischemic stroke
  • Track 6-15Neuro critical Care

Neuro-Oncology is study of treatment for patients with cancers of the brain and nervous system. Basically neuro-oncology focuses on primary and metastasis tumour which includes Astrocytoma, Glioma, Glioblastoma multiforme, Ependymoma, Brain Stem GliomasGerm Cell and Pineal Region Tumors, Spinal Cord Tumours, Leptomeningeal Metastasis and other Brain Metastasis. 

The brain cancer or tumors treatments includeRadiotherapyChemotherapy, Corticosteroids and Neurosurgical Intervention to curing Neuro-oncological conditions. A new approach of use of blood biomarkers of glioblastoma for treating primary tumour in adults.

  • Track 7-1Neuro-oncology
  • Track 7-2Neurological disorders and surgery
  • Track 7-3Adavancements in neurooncology imaging
  • Track 7-4Imaging in neurooncology
  • Track 7-5Biomarkers in neuro-oncology
  • Track 7-6Neurosurgery of tumours
  • Track 7-7Antitumour Therapies
  • Track 7-8Neuro-oncological infections
  • Track 7-9Spinal cord tumours diagnosis
  • Track 7-10Influence of cancer on Stroke Risk
  • Track 7-11Neuro-oncology and metatasis
  • Track 7-12Neuro Pediatrics

Neurorehabilitation is a complex medical process which aims to aid recovery from a nervous system injury. Neurological rehabilitation program is aimed to create awareness about the neurological disorders and its diagnosis. Neurologist, physiatristrehabilitation nurse and therapist provide special guidance and care to stroke affected patients.

The outcomes of strokes are greatly affected by many factors which include age, gender, education level, stroke type, concordance, diet and nutrition, physical activity, smoking, tobacco and alcohol addiction. Out of which the age and severity of deficit have repeatedly been found to be most major factors. The swallowing, cognitive and emotional therapies are given to stroke patients. The technology assisted facilities such as Cranial electrical stimulation and Transcranial magnetic stimulation are helpful in brain recovery.

  • Track 8-1Stroke rehabilitation: Care and guidance
  • Track 8-2Electrical Brain stimulation
  • Track 8-3Advancements in stroke therapy
  • Track 8-4Post-stroke rehabilitation
  • Track 8-5Hemiparesis and motor recovery of limbs
  • Track 8-6Nutrition and Swallowing technique
  • Track 8-7Neuropsychological therapies
  • Track 8-8Magnetic Brain recovery
  • Track 8-9Technology Innovations in Stroke
  • Track 8-10Factors effecting the outcome of strokes
  • Track 8-11stroke survivors

Diabetes management of persons before and after stroke is done by controlling hyperglycaemia and hypoglycaemia conditions. Estimates of risk of ischemic stroke in people with diabetes range from 2-3 fold increase in men and 2-5 fold increase in women. Carotid artery stenting is an endovascular surgery performed when a stent is deployed within the lumen of the carotid artery to prevent a stroke by treating narrowing of the carotid artery.  CAS is used to treat narrowing of the carotid artery in high-risk patients

The cognitive approaches and rehabilitation therapy of stroke are cognitive impairment involves a vast array of difficulties, including memory, attention, orientation, judgment, problem solving skills visuospatial deficits and recovery of memory impairments following stroke. Cellular approaches may be an effective alternative to conventional disease management strategies of ischemic stroke with new innovative use of endogenous stem cells and progenitor cells in the adult brain after stroke. Neurodevelopmental therapy (NDT) or Bobath approach has been the most widely used as therapeutic approach for remediation of motor control deficits with patients after stroke.

  • Track 9-1Role of anticoagulants in neurological disorders
  • Track 9-2Advancements in Neuromuscular disorders
  • Track 9-3Post-stroke recovery therapies
  • Track 9-4Treatment of Diaschsis and related conditions
  • Track 9-5Growth factors as a treatment for stroke
  • Track 9-6Neurodevelopmental therapy (NDT)
  • Track 9-7Electromagnetic stroke recovery
  • Track 9-8Cognitive and cellular approaches to stroke recovery
  • Track 9-9Management of atrial fibrillation
  • Track 9-10Endovascular surgery
  • Track 9-11Blood pressure control
  • Track 9-12Diabetes management in stroke
  • Track 9-13Spinal Muscular Atrophy treatment
  • Track 9-14Stem cell technology: Neuron replacement
  • Track 9-15Injections based therapy
  • Track 9-16Antiplatelet therapy and thrombolytic therapy
  • Track 9-17Neuro drugs and blood brain barriers
  • Track 9-18Advancements in Stroke therapies